Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Income Tax Disclosure [Abstract] |
|
| Schedule of components of loss before income taxes |
| Schedule of components of loss before income taxes | |
| | |
| |
| | |
Year ended December 31, | |
| | |
2025 | | |
2024 | |
| Domestic (U.S.) | |
$ | (5,466,353 | ) | |
$ | (6,251,785 | ) |
| Foreign (U.K.) | |
| 2,966,647 | | |
| 2,460,945 | |
| Foreign (Germany) | |
| (164,853 | ) | |
| (153,332 | ) |
| Foreign (Switzerland) | |
| (16,301 | ) | |
| (16,103 | ) |
| Loss before income taxes | |
$ | (2,680,860 | ) | |
$ | (3,960,275 | ) |
|
| Schedule of components of loss before income taxes |
| Schedule of components of loss before income taxes | |
| | |
| | |
| | |
| |
| | |
Year ended December 31, | |
| | |
2025 | | |
2024 | |
| Federal | |
$ | (562,981 | ) | |
| 21.0% | | |
$ | (831,658 | ) | |
| 21.0% | |
| Domestic Federal | |
| | | |
| | | |
| | | |
| | |
| Tax credits | |
| (117,620 | ) | |
| 4.4 | | |
| (120,379 | ) | |
| 3.0 | |
| Effect of cross-border tax laws | |
| 430,088 | | |
| (16.0 | ) | |
| 153,506 | | |
| (3.9 | ) |
| Change in valuation allowance | |
| (759,494 | ) | |
| 28.3 | | |
| 1,057,187 | | |
| (26.7 | ) |
| Share-based expense, net | |
| 1,105,585 | | |
| (41.2 | ) | |
| 223,523 | | |
| (5.6 | ) |
| Other | |
| 489,375 | | |
| (18.3 | ) | |
| (962 | ) | |
| – | |
| Foreign | |
| | | |
| | | |
| | | |
| | |
| United Kingdom | |
| | | |
| | | |
| | | |
| | |
| Rate differential | |
| 113,467 | | |
| (4.2 | ) | |
| 93,731 | | |
| (2.4 | ) |
| Valuation allowance | |
| (703,161 | ) | |
| 26.2 | | |
| 37,533 | | |
| (0.9 | ) |
| Attribute adjustments | |
| – | | |
| – | | |
| (617,109 | ) | |
| 15.6 | |
| Other | |
| (33,301 | ) | |
| 1.2 | | |
| (30,954 | ) | |
| 0.8 | |
| Other | |
| 38,042 | | |
| (1.4 | ) | |
| 35,582 | | |
| (0.9) | |
| Net benefit for income taxes | |
$ | – | | |
| – | | |
$ | – | | |
| – | |
|
| Schedule of deferred tax assets and liabilities |
| Schedule of deferred tax assets and liabilities | |
| | |
| |
| | |
Year ended December 31, | |
| | |
2025 | | |
2024 | |
| Deferred tax assets: | |
| | | |
| | |
| U.K. net operating loss carryforwards | |
$ | 21,235,111 | | |
$ | 21,938,273 | |
| U.K. capital loss carryforwards | |
| 1,745,821 | | |
| 1,745,821 | |
| U.S. federal net operating loss carryforwards | |
| 8,127,082 | | |
| 7,518,011 | |
| Switzerland net operating loss carryforwards | |
| 22,480 | | |
| 13,392 | |
| IPR&D | |
| 534,753 | | |
| 586,746 | |
| Share-based expense | |
| 429,581 | | |
| 1,979,372 | |
| Enhanced research and development tax credits | |
| 2,278,855 | | |
| 2,165,119 | |
| Germany net operating loss carryforwards | |
| 844,276 | | |
| 700,617 | |
| Capitalized research and experimental expenditure | |
| 1,660,590 | | |
| 1,804,979 | |
| U.S. state net operating loss carryforwards | |
| 2,762,009 | | |
| 2,468,919 | |
| Other | |
| 151,294 | | |
| 208,288 | |
| Total deferred tax assets before valuation allowance | |
| 39,791,852 | | |
| 41,129,537 | |
| Valuation allowance for deferred tax assets | |
| (39,791,852 | ) | |
| (41,129,537 | ) |
| Net deferred tax assets | |
| – | | |
| – | |
| Deferred tax liabilities: | |
| | | |
| | |
| Total deferred tax liabilities | |
| – | | |
| – | |
| Net deferred liability | |
$ | – | | |
$ | – | |
|